Drug delivery devices are systems employed to conduct a drug to a specific site of the body, where it should be released and absorbed. Reservoir-type systems are devices in which the drug is contained within a nucleus isolated from the outside environment by a thin polymeric layer, which regulates a diffusion process driven by a functional concentration gradient. In this study two reservoir-type drug delivery devices based on polycaprolactone (PCL) were developed for the release of progesterone (PG) using the Selective Laser Sintering (SLS) technique, in order to investigate the influence of the concentration gradient promoted during manufacturing on the drug delivery profile. Two types of controlled-drug-release devices were fabricated; the first containing only the polycaprolactone polymer in the reservoir wall (system R) and the second containing PLC and 15% of progesterone in the wall (system R*). The cores of both reservoirs were filled with 40 mg of progesterone. A study on the degradation was conducted to assess the release process of the two systems. The drug delivery results showed that for both reservoirs the amount of drug released was linear over time, featuring zero-order release kinetics. The higher mass loss with the incorporation of the drug into the wall of the reservoir was associated with faster release of the drug to the medium. The feasibility of building three-dimensional parts using the SLS technique allowed the construction of reservoir-type devices based on a functional gradient for the controlled-release of the drug.
This paper describes the properties of porous polycaprolactone/ibuprofen implants fabricated by SLS for orbital floor repair. The specimens prepared showed homogeneous morphology and pore interconnectivity. PCL/ibuprofen specimens presented a higher degree of sintering than pure PCL specimens. The PCL/ibuprofen specimen sintered under the highest laser power showed the lowest crystallinity value due to a fast cooling rate resulting from the strong laser absorption presented by the PCL/ibuprofen mixture. The specimens showed a significant increase in the flexural modulus when the laser energy density used in the manufacturing was increased. The DMA tests indicated that solubilization and the formation of secondary chemical interactions between the drug and the PCL did not occur. The PCL/ibuprofen specimens showed the occurrence of non-linear drug release with respect to time, suggesting Fickian release kinetics via a diffusion mechanism. The release profile for porous plates of PCL/ibuprofen prepared by selective laser sintering indicated that these devices could be applied for bone regeneration and the control of the inflammatory process soon after implantation